ClinConnect ClinConnect Logo
Search / Trial NCT06955663

Exercise Support and Rehabilitation for Patients After Spontaneous Coronary Artery Dissection

Launched by UNIVERSITY OF LEICESTER · Apr 24, 2025

Trial Information

Current as of August 26, 2025

Not yet recruiting

Keywords

Sponaneous Coronary Artery Dissection Exercise Randomised Controlled Trial Rehabilitaiton Fesability

ClinConnect Summary

This clinical trial is looking at how a remote exercise program can help women recover after experiencing a spontaneous coronary artery dissection (SCAD), which is a type of heart attack that mainly affects otherwise healthy women. The study aims to see if this kind of exercise program can be successfully done at home, as traditional cardiac rehab programs are often designed for older patients and may not be suitable for younger women recovering from SCAD.

To be eligible for this trial, participants need to be women aged 18 or older who have been diagnosed with SCAD and referred to the Leicester SCAD clinic. They should also have a good heart function and be able to travel to the clinic for appointments. Unfortunately, those without access to a smartphone or the internet, or who cannot understand explanations in English, won't be able to participate. If you join the trial, you can expect to take part in exercise sessions that are tailored to your recovery needs, all while being supported remotely.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Female
  • Aged ≥18 years.
  • Diagnosed with angiographically confirmed SCAD and referred to the Leicester SCAD clinic.
  • Ejection fraction \>45%.
  • Blood pressure \<180/100. Resting heart rate \<100bpm
  • Exclusion Criteria:
  • No SCAD diagnosis.
  • Unable to travel to Leicester Hospital for their SCAD clinic appointment.
  • Unable to give informed consent.
  • No smart phone or internet access
  • Unable to understand verbal explanations in English.

About University Of Leicester

The University of Leicester is a leading research institution in the UK, renowned for its commitment to advancing scientific knowledge and improving healthcare through innovative clinical trials. The university fosters a collaborative environment that integrates diverse disciplines, enabling the development of cutting-edge research initiatives aimed at addressing pressing medical challenges. With a focus on ethical practices and patient-centered outcomes, the University of Leicester is dedicated to enhancing clinical research methodologies and contributing to the advancement of medical sciences, ultimately striving to translate research findings into tangible health benefits for communities.

Locations

Leicester, Leicestershire, United Kingdom

Patients applied

0 patients applied

Trial Officials

David Adlam, BA BM BCh DPhil FRCP FESC

Principal Investigator

University of Leicester

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported